HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Sarcoma of soft tissue — Clinical Guidelines

Overview

Soft tissue sarcomas (STS) are rare malignancies originating from mesenchymal cells, encompassing a heterogeneous group of tumors that can arise from various tissues such as fat, muscle, nerves, and blood vessels. Accurate diagnosis and multidisciplinary management are crucial for optimal outcomes. 4 5

Diagnosis

Biopsy: Mandatory for definitive diagnosis.

Imaging: MRI and CT are essential for assessing tumor extent and local infiltration. 2 5

Pathology Reporting: Utilize standardized datasets for accurate reporting of biopsy and resection specimens. 3

Grading: Based on histologic features, with higher grades indicating poorer prognosis. 4

Ki-67 Assessment: Evaluate proliferation, particularly noting higher expression in peripheral tumor areas. 13

Management

Surgical Resection: Wide excision with negative margins is the primary treatment for localized disease. 1 4 5

Radiotherapy: Indicated for large, deep, high-grade tumors or after marginal resection unsuitable for re-excision. 5

Neoadjuvant Therapy: Considered for selected cases, with imaging assessment post-therapy crucial. 2

Adjuvant Chemotherapy: Perioperative chemotherapy may be considered based on tumor grade and size. 5

Trabectedin: Used in advanced cases; monitor for potential cardiotoxicity, especially in elderly patients. 7

Intraoperative Radiotherapy (IORT): Option for selected patients with localized recurrence or primary tumors. 17

Special Populations

Elderly Patients: Geriatric factors significantly impact surgical outcomes and survival; multidisciplinary assessment is essential. 10

Immunocompromised Patients: Increased risk of unusual presentations and locations, such as mediastinum. 11

Key Recommendations

Surgical Excision with Negative Margins: Essential for localized soft tissue sarcoma to minimize recurrence. (Evidence: Strong 1 4)

Multidisciplinary Team Approach: Required for comprehensive evaluation and management of STS. (Evidence: Expert opinion 4)

Standardized Pathology Reporting: Implement international consensus datasets for accurate reporting. (Evidence: Moderate 3)

Consider Radiotherapy for High-Risk Features: Indicated in large, deep, high-grade tumors or after inadequate surgical margins. (Evidence: Moderate 5)

Monitor for Cardiotoxicity with Trabectedin: Especially in elderly patients receiving this therapy. (Evidence: Weak 7)

References

1 Bordeaux J, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K et al.. Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2025. link 2 Noebauer-Huhmann IM, Vilanova JC, Papakonstantinou O, Weber MA, Lalam RK, Nikodinovska VV et al.. Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2024: imaging immediately after neoadjuvant therapy in soft tissue sarcoma, soft tissue tumor surveillance, and the role of interventional radiology. European radiology 2025. link 3 Dei Tos AP, Webster F, Agaimy A, Bovée J, Dickson B, Doyle L et al.. Datasets for reporting of soft-tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 2023. link 4 von Mehren M, Kane JM, Agulnik M, Bui MM, Carr-Ascher J, Choy E et al.. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2022. link 5 de Juan Ferré A, Álvarez Álvarez R, Casado Herráez A, Cruz Jurado J, Estival González A, Martín-Broto J et al.. SEOM Clinical Guideline of management of soft-tissue sarcoma (2020). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021. link 6 Shi L, Wang Y, Li L, Chou D, Zhao Y, Zhang S et al.. Prognostic value of pretreatment anemia in patients with soft tissue sarcoma: A meta-analysis. Medicine 2021. link 7 Doherty GJ, Davidson D, Wong HH, Hatcher HM. Cardiotoxicity with trabectedin in the treatment of advanced soft tissue sarcoma. Anti-cancer drugs 2019. link 8 Valenti V. Hospital Volume Versus Good Clinical Practice. The oncologist 2019. link 9 Bourcier K, Le Cesne A, Tselikas L, Adam J, Mir O, Honore C et al.. Basic Knowledge in Soft Tissue Sarcoma. Cardiovascular and interventional radiology 2019. link 10 Tsuda Y, Ogura K, Kobayashi E, Hiruma T, Iwata S, Asano N et al.. Impact of geriatric factors on surgical and prognostic outcomes in elderly patients with soft-tissue sarcoma. Japanese journal of clinical oncology 2017. link 11 Hernandez A, Gill FI, Aventura E, Mason C, Shellito J. Mediastinal pleomorphic sarcoma in an immunodeficient patient: case report and review of the literature. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 2012. link 12 Dent LL, Cardona CY, Buchholz MC, Peebles R, Scott JD, Beech DJ et al.. Soft tissue sarcoma with metastasis to the stomach: a case report. World journal of gastroenterology 2010. link 13 Fernebro J, Engellau J, Persson A, Rydholm A, Nilbert M. Standardizing evaluation of sarcoma proliferation- higher Ki-67 expression in the tumor periphery than the center. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2007. link 14 Weber R, Knaup P, Knietitg R, Haux R, Merzweiler A, Mludek V et al.. Object-oriented business process analysis of the cooperative soft tissue sarcoma trial of the german society for paediatric oncology and haematology (GPOH). Studies in health technology and informatics 2001. link 15 Engellau J, Akerman M, Anderson H, Domanski HA, Rambech E, Alvegård TA et al.. Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Applied immunohistochemistry & molecular morphology : AIMM 2001. link 16 Moley JF, Eberlein TJ. Soft-tissue sarcomas. The Surgical clinics of North America 2000. link70207-3) 17 Dubois JB, Debrigode C, Hay M, Gely S, Rouanet P, Saint-Aubert B et al.. Intra-operative radiotherapy in soft tissue sarcomas. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995. link01515-i) 18 McConnell R, Anderson K, Russell W, Anderson KE, Clapp R, Silbergeld EK et al.. Angiosarcoma, porphyria cutanea tarda, and probable chloracne in a worker exposed to waste oil contaminated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. British journal of industrial medicine 1993. link 19 Tenzer JA, Rypins RD, Jakowatz JG. Malignant cystosarcoma phyllodes metastatic to the maxilla. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 1988. link90307-2) 20 Leader M, Collins M, Patel J, Henry K. Desmin: its value as a marker of muscle derived tumours using a commercial antibody. Virchows Archiv. A, Pathological anatomy and histopathology 1987. link 21 Donath J, Chawla K, Mehra S, Azueta V. Unilateral giant lung metastasis of uterine leiomyosarcoma: diagnostic pitfalls in an unusual case. Journal of the National Medical Association 1986. link 22 Agamanolis DP, Dasu S, Krill CE. Tumors of skeletal muscle. Human pathology 1986. link80198-8) 23 Brooks JJ. The significance of double phenotypic patterns and markers in human sarcomas. A new model of mesenchymal differentiation. The American journal of pathology 1986. link 24 Morgan KG, Gray C. Malignant epithelioid schwannoma of superficial soft tissue? A case report with immunohistology and electron microscopy. Histopathology 1985. link 25 Reichert CM, Rosenstein M, Von Glatz J, Hsu SM, Rosenberg SA. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment. Laboratory investigation; a journal of technical methods and pathology 1985. link 26 Brooks JJ. Immunohistochemistry of soft tissue tumors: progress and prospects. Human pathology 1982. link80089-0) 27 Qizilbash AH. Cystosarcoma phyllodes with liposarcomatous stroma. American journal of clinical pathology 1976. link

Sarcoma of soft tissue